Bifogade filer
LIDDS is declared bankrupt – delisting from First North
Prenumeration
Kalender
| Est. tid* | ||
| 2026-11-19 | 07:00 | Kvartalsrapport 2026-Q3 |
| 2026-08-27 | 07:00 | Kvartalsrapport 2026-Q2 |
| 2026-05-28 | N/A | Årsstämma |
| 2026-05-28 | 07:00 | Kvartalsrapport 2026-Q1 |
| 2026-03-26 | 08:00 | Bokslutskommuniké 2025 |
| 2026-01-28 | - | Extra Bolagsstämma 2026 |
| 2025-12-18 | - | Extra Bolagsstämma 2025 |
| 2025-11-20 | - | Kvartalsrapport 2025-Q3 |
| 2025-08-28 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-30 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2025-05-28 | - | Årsstämma |
| 2025-05-28 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-20 | - | Bokslutskommuniké 2024 |
| 2024-11-21 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-28 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-30 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-16 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2024-05-15 | - | Årsstämma |
| 2024-02-27 | - | Extra Bolagsstämma 2024 |
| 2024-02-22 | - | Bokslutskommuniké 2023 |
| 2023-11-28 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-30 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-30 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2023-05-29 | - | Årsstämma |
| 2023-05-29 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-13 | - | Bokslutskommuniké 2022 |
| 2023-01-09 | - | Extra Bolagsstämma 2022 |
| 2022-11-28 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-02 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2022-06-01 | - | Årsstämma |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-11-22 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-18 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2021-05-18 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-17 | - | Årsstämma |
| 2021-02-25 | - | Bokslutskommuniké 2020 |
| 2020-11-19 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2020-05-14 | - | Årsstämma |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-28 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-29 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-17 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2019-05-16 | - | Årsstämma |
| 2019-05-16 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-28 | - | Bokslutskommuniké 2018 |
| 2018-11-29 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-30 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2018-05-16 | - | Årsstämma |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-09 | - | Kvartalsrapport 2017-Q3 |
| 2017-10-06 | - | Extra Bolagsstämma 2017 |
| 2017-08-31 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2017-05-11 | - | Årsstämma |
| 2017-05-11 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-10-27 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-09 | - | Extra Bolagsstämma 2016 |
| 2016-04-22 | - | Årsstämma |
| 2016-04-22 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-21 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2016-02-10 | - | Bokslutskommuniké 2015 |
| 2015-10-29 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-22 | - | X-dag ordinarie utdelning LIDDS 0.00 SEK |
| 2015-04-21 | - | Årsstämma |
| 2015-04-21 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-20 | - | Bokslutskommuniké 2014 |
| 2014-11-11 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-21 | - | Kvartalsrapport 2014-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
On 13 February 2026, the Gothenburg District Court decided to file LIDDS AB (publ) in liquidation ("the Company") for bankruptcy.
Mona Jonasson, Layer at law firm NORDIA Göteborg KB, has been appointed as bankruptcy trustee.
The background to the bankruptcy decision is, as previously announced, that the liquidator appointed by the Swedish Companies Registration Office, Lawyer Michael Amosy, has determined that the company’s assets are not expected to cover the company’s debts and the costs of carrying out the liquidation. Therefore, the liquidator has applied for the company to be declared bankrupt.
Nasdaq Stockholm AB, which had previously decided to halt trading in the company’s shares on Nasdaq First North Growth Market, has today, in connection with the bankruptcy decision, announced its decision to delist the company’s shares with immediate effect.
Further information regarding the bankruptcy proceedings will be provided by the bankruptcy trustee.
For additional information, please contact
Lawyer Mona Jonasson
Phone: +46 (0)705 97 98 88
E-mail: mona.jonasson@nordialaw.com
LIDDS’ Certified Adviser is G&W Fondkommission
LIDDS in brief:
LIDDS is a Swedish pharmaceutical company focused on the development of oncology drugs. LIDDS has a proprietary drug delivery technology, NanoZolid®, on which several projects are based. With NanoZolid, LIDDS can formulate drugs for local/intratumoral administration, with a maintained and controlled release and with minimal negative side-effects. In addition to these projects, LIDDS develops proprietary drug candidate NOV202 that have shown very good results in pre-clinical studies. The company is listed on Nasdaq First North Growth market.